Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000541324 | SCV000650946 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-11-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001707736 | SCV001935823 | benign | not provided | 2020-07-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456212 | SCV002737154 | likely benign | Cardiovascular phenotype | 2020-01-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003486876 | SCV004240630 | benign | Cardiomyopathy | 2023-06-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003962561 | SCV004781818 | likely benign | FLNC-related disorder | 2023-05-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |